Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index; 7 of the 22 sources its claims cite were checked for support.
Abstract
OBJECTIVE—A lower in vivo mitochondrial function has been reported in both type 2 diabetic patients and first-degree relatives of type 2 diabetic patients. The nature of this reduction is unknown. Here, we tested the hypothesis that a lower intrinsic mitochondrial respiratory capacity may underlie lower in vivo mitochondrial function observed in diabetic patients. RESEARCH DESIGN AND METHODS—Ten overweight diabetic patients, 12 first-degree relatives, and 16 control subjects, all men, matched for age and BMI, participated in this study. Insulin sensitivity was measured with a hyperinsulinemic-euglycemic clamp. Ex vivo intrinsic mitochondrial respiratory capacity was determined in permeabilized skinned muscle fibers using high-resolution respirometry and normalized for mitochondrial content. In vivo mitochondrial function was determined by measuring phosphocreatine recovery half-time after exercise using 31P-magnetic resonance spectroscopy. RESULTS—Insulin-stimulated glucose disposal was lower in diabetic patients compared with control subjects (11.2 ± 2.8 vs. 28.9 ± 3.7 μmol · kg−1 fat-free mass · min−1, respectively; P = 0.003), with intermediate values for first-degree relatives (22.1 ± 3.4 μmol · kg−1 fat-free mass · min−1). In vivo mitochondrial function was 25% lower in diabetic patients (P = 0.034) and 23% lower in first-degree relatives, but the latter did not reach statistical significance (P = 0.08). Interestingly, ADP-stimulated basal respiration was 35% lower in diabetic patients (P = 0.031), and fluoro-carbonyl cyanide phenylhydrazone–driven maximal mitochondrial respiratory capacity was 31% lower in diabetic patients (P = 0.05) compared with control subjects with intermediate values for first-degree relatives. CONCLUSIONS—A reduced basal ADP-stimulated and maximal mitochondrial respiratory capacity underlies the reduction in in vivo mitochondrial function, independent of mitochondrial content. A reduced capacity at both the level of the electron transport chain and phosphorylation system underlies this impaired mitochondrial capacity.
Overview
CoChat Summary
TL;DR
In male type 2 diabetic patients, in vivo mitochondrial function (phosphocreatine recovery half-time) was 25% lower than in age- and BMI-matched control subjects, and ex vivo ADP-stimulated state 3 respiration was 35% lower after normalization for mitochondrial content. These intrinsic defects involved both electron transport chain and phosphorylation system capacity, with intermediate or tendency values in first-degree relatives.
Key findings
- Insulin-stimulated glucose disposal was lower in diabetic patients than control subjects (11.2 ± 2.8 vs. 28.9 ± 3.7 μmol · kg−1 fat-free mass · min−1, P = 0.003), with intermediate values in first-degree relatives (22.1 ± 3.4 μmol · kg−1 fat-free mass · min−1).
- In vivo mitochondrial function was 25% lower in diabetic patients (PCr recovery half-time 23.8 ± 2.0 vs. 17.9 ± 1.2 s, P = 0.034); first-degree relatives had a 23% longer PCr-t1/2 (23.1 ± 2.0 s) but this did not reach significance (P = 0.08).
- After normalization for mitochondrial content, ADP-stimulated state 3 respiration was 35% lower in diabetic patients (P = 0.031), and FCCP-driven maximal respiratory capacity was 31% lower (P = 0.05); state 4 respiration did not differ between groups.
- Mitochondrial density (mtDNA copy number and citrate synthase activity) did not differ between groups, indicating that the lower respiration was intrinsic rather than due to reduced mitochondrial content.
Methods
- Cross-sectional study of 10 male type 2 diabetic patients, 12 male first-degree relatives, and 16 male control subjects matched for age and BMI; insulin sensitivity was measured with a 3-h hyperinsulinemic-euglycemic clamp using [6,6-2H2]glucose.
- In vivo mitochondrial function was determined by 31P-MRS as phosphocreatine recovery half-time after knee-extension exercise; ex vivo mitochondrial respiration was measured by high-resolution respirometry in permeabilized skinned muscle fibers, with normalization to mtDNA copy number or citrate synthase activity.
- Group differences were analyzed by one-way ANOVA with Tukey’s post hoc correction; Spearman correlations were computed; significance was set at P < 0.05.
Limitations
- Stated: physical activity was assessed by questionnaire and maximal aerobic capacity and was similar between groups, but the paper notes the reason for lower intrinsic mitochondrial capacity is unknown and may involve ultrastructural mitochondrial changes; whether mitochondrial size determines overall capacity needs further investigation.
- Evident: all participants were men, group sizes were modest (10 diabetic patients, 12 first-degree relatives, 16 control subjects), and first-degree relative differences were not statistically significant (e.g., PCr-t1/2 P = 0.08), limiting power and generalizability.
- Evident: the cross-sectional design cannot establish whether intrinsic mitochondrial defects precede or are a consequence of type 2 diabetes or insulin resistance.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
5 Valid · 0 Not valid · 10 Not checked · 62 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In contrast, using an alternative method to measure in vivo mitochondrial function with 31P-MRS, we recently showed an ∼40% lower mitochondrial function in type 2 diabetic patients compared with age- and BMI-matched control subjects (8).”
§ Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients > Abstract
What the sources say
- Partly supportedcites [8] Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, van Engelshoven JM, Mensink M, Schrauwen P: Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50:113–120,2007 sourceExperimental — accuracy not yet measured
The In vivo mitochondrial function section reports a 45% longer PCr recovery half-time in patients with type 2 diabetes, indicating impaired mitochondrial function; the Discussion describes a 45% drop. However, the Subject characteristics section says the groups were BMI-matched but differed significantly in age (61.8 versus 56.1 years), so they were not age-matched. Page numbers are unavailable in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“So far, three studies have reported mitochondrial function ex vivo in a diabetic population (13–15), with conflicting results.”
§ Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients > Abstract
What the sources say
- Supportedcites [13] Mogensen M, Sahlin K, Fernstrom M, Glintborg D, Vind BF, Beck-Nielsen H, Hojlund K: Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56:1592–1599,2007 source
The Discussion (page not provided) reports measurements of respiration in isolated skeletal-muscle mitochondria from patients with type 2 diabetes and nondiabetic controls. This identifies the paper as an ex vivo mitochondrial-function study in a diabetic population, the role for which it is cited among the three studies. (LLM, conf=0.91)
- Supportedcites [14] Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, Dela F: Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50:790–796,2007 source
The Subjects and methods passage identifies this paper as a study measuring mitochondrial respiration in permeabilised skeletal muscle fibres from men with type 2 diabetes, supporting its inclusion among ex vivo studies. The Discussion reports normal mitochondrial function after adjustment for mitochondrial content and says this does not support other investigations reporting dysfunction, consistent with conflicting results. (LLM, conf=0.92)
- Supportedcites [15] Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS: Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci U S A 100:7996–8001,2003 source
This paper is one of the studies the citation group identifies. Materials and Methods describes measuring ATP production in mitochondria separated from muscle biopsies, including biopsies from people with type 2 diabetes; Results reports the diabetic group’s findings. The statement that results conflict concerns the three studies collectively, not a finding attributed to this paper alone. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We confirmed our previous finding (8) of compromised in vivo mitochondrial function, determined as the rate of PCr recovery after exercise in type 2 diabetic patients compared with age- and BMI-matched control subjects”
§ Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients > DISCUSSION
What the sources say
- Partly supportedcites [8] Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, van Engelshoven JM, Mensink M, Schrauwen P: Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50:113–120,2007 sourceExperimental — accuracy not yet measured
The core of the claim is confirmed: 'In vivo mitochondrial function' (Results) reports mean PCr recovery half-time 45% longer in the type 2 diabetes group (27.3±3.5 vs 18.7±0.9 s, p<0.05), 'indicating impaired in vivo mitochondrial function', and the Abstract and Discussion repeat this. However, the qualifier 'age- and BMI-matched' is not what this study did: 'Subject characteristics' states the groups were 'carefully matched for BMI (29.4±1.0 and 29.3±0.9 kg/m2)' but age was 61.8±1.3 vs 56.1±2.3 years (p<0.05), and the Discussion explicitly addresses this 6-year age difference as a possible contributor. So the age-matching description of the comparison is unsupported (indeed contrary to the source's own data). (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mitochondrial density measured as mtDNA copy number and as citrate synthase activity was not different between groups (mtDNA copy number 5,813 ± 388, 5,573 ± 716, and 5,621 ± 430 arbitrary units; citrate synthase activity 92 ± 4.8, 103 ± 13.0, and 89 ± 7.4 μmol · g−1 protein · min−1, respectively, in diabetic patients, first-degree relatives, and control subjects; NS).”
§ Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients > RESULTS > Mitochondrial density.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In vivo mitochondrial function was 25% lower in diabetic patients (P = 0.034) and 23% lower in first-degree relatives, but the latter did not reach statistical significance (P = 0.08).”
- Also stated in: § In vivo mitochondrial function. · hedged
“Mean PCr recovery half-time (PCr-t1/2) was prolonged by 25% in diabetic patients compared with control subjects (23.8 ± 2.0 vs. 17.9 ± 1.2 s, respectively; P = 0.034) (Fig. 2), indicating impaired in vivo mitochondrial function in diabetic patients.”
§ Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § In vivo mitochondrial function. · hedged
40 more claims
Create a free account to see all 77 claims and to verify the 15 references still open.
- It may state two separate claims as one. 25
- Probably not a substantial claim. 9
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although the existence of mitochondrial abnormalities in patients with type 2 diabetes has been extensively reported during the last decade (1–5), there is no evidence that a reduced mitochondrial function is a primary factor in the pathophysiology of this disease.”
From Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance (2010) · cites this paper as [4]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a similar reduction in intrinsic mitochondrial capacity, without differences in mitochondrial content, was recently reported by us in type 2 diabetic patients and first degree relatives when compared with BMI- and age-matched obese control subjects (4).”
From Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance (2010) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it has generally been assumed that a reduction in muscle mitochondrial function will result in reductions in whole-body fat oxidative capacity (3–5,42,43).”
From Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance (2010) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, decreased mitochondrial respiration was found in first-degree relatives of individuals with T2DM139.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most importantly, a decrease in mitochondrial respiration was reported in the first-degree relatives of individual with T2DM (Phielix et al., 2008) indicating that mitochondrial dysfunction may precede the onset of full blown T2DM.”
From Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet (2019) · cites this paper as Phielix et al., 2008
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 2×
“To measure peripheral insulin sensitivity, a 3-h hyperinsulinemic-euglycemic (40 mU m 2 min (1)) clamp, according to DeFronzo (18), was performed after an overnight fast with primed infusion of [6,6-(2)H2]glucose (0.”
MethodInfluentialCellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Calculation of substrate oxidation rates in vivo from gaseous exchange.
Frayn, K. N. (1983) · Journal of Applied Physiology · doi:10.1152/jappl.1983.55.2.628 · Cited by 2,365 · cited 1×
“Fat and carbohydrate oxidation were calculated using stoichiometric equations according to Frayn (25) with the assumption that protein oxidation was negligible.”
MethodDysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321 · cited 1×
“In that respect, smaller mitochondria have been reported for type 2 diabetic patients (1), and mitochondrial size was related to insulin sensitivity (1,26).”
BackgroundImpaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 2×
“Lower basal ATP synthesis rate in insulin-resistant first-degree relatives has been reported previously (6) when compared with insulin-sensitive healthy control subjects.”
ResultMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 2×
“Using this methodology, they reported that resting muscular ATP synthesis was decreased by 40% in insulinresistant elderly compared with insulin-sensitive young control subjects (3).”
BackgroundPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
The Gross Composition of the Body
SIRI, W. E. (1956) · Advances in Biological and Medical Physics · doi:10.1016/b978-1-4832-3110-5.50011-x · Cited by 1,765 · cited 1×
“determined using hydrostatic weighing (17).”
Diet, muscle glycogen and physical performance.
Bergström, J., Hermansen, L., Hultman, E., & Saltin, B. (1967) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1967.tb03720.x · Cited by 1,740
Cited by
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“It has also been proposed that T2DM development may be a direct consequence of defects in the oxidative phosphorylation system and the electron transport chain (ETC) rather than a decrease in mitochondrial content [126].”
BackgroundTimmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320
“On day 30, when subjects left the respiration chamber, a muscle biopsy was taken from the vastus lateralis muscle under local anesthesia (2% lidocaine), as previously described (Phielix et al., 2008).”
BackgroundMethodInfluentialSelf-citationBiomarkers of mitochondrial content in skeletal muscle of healthy young human subjects
Larsen, S., Nielsen, J., Hansen, C. N., Nielsen, L. B., Wibrand, F., Stride, N., Schroder, H. D., Boushel, R., Helge, J. W., Dela, F., et al. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.230185 · Cited by 1,180
“…or permeabilized muscle fibres have shown that acute exercise (Fernström et al. 2004), high fat diet (Anderson et al. 2009), type 2 diabetes (Phielix et al. 2008), chronic obstructive pulmonary disease (Naimi et al. 2011) and obesity (Anderson et al. 2008) may change the intrinsic…”
BackgroundMitochondrial and metabolic dysfunction in ageing and age-related diseases
Amorim, J. A., Coppotelli, G., Rolo, A. P., Palmeira, C. M., Ross, J. M., & Sinclair, D. A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00626-7 · Cited by 990
DeFronzo, R. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1684-1 · Cited by 879
“Mitochondrial dysfunction, lipotoxicity and thiazolidinediones Impaired ATP synthesis and mitochondrial dysfunction have been demonstrated in insulin-resistant states including ageing, offspring of diabetic parents, obesity and type 2 diabetes mellitus [175–179].”
Background
Metadata
- Authors
- Phielix, E., Schrauwen-Hinderling, V. B., Mensink, M., Lenaers, E., Meex, R., Hoeks, J., Kooi, M. E., Moonen-Kornips, E., Sels, J.-P., Hesselink, M. K. C., & Schrauwen, P.
- Affiliations
- Department of Human Biology, Maastricht University, Maastricht, the Netherlands
- Maastricht University (NL)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Schrauwen, Patrick
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-11-01
- Volume
- 57
- Issue
- 11
- Pages
- 2943-2949
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2570390
- OpenAlex
- W2112906476
- Cited by
- 359
- References
- 31
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 13 · 2023: 26 · 2022: 28 · 2021: 26 · 2020: 20 · 2019: 17 · 2018: 14 · 2017: 12 · 2016: 28 · 2015: 13 · 2014: 17 · 2013: 25 · 2012: 29
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by-nc-nd)
- TU/e Research Portal (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- TU/e Research Portal (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016.066.359)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, mitochondrial dysfunction, ADP-stimulated respiration, skeletal muscle, first-degree relatives, insulin sensitivity, insulin-stimulated glucose disposal, phosphocreatine recovery, electron transport chain, mitochondrial phosphorylation, F1-ATPase
- MeSH terms
- Adenosine Diphosphate, Diabetes Mellitus, Type 2, Glucose, Humans, Insulin, Male, Middle Aged, Mitochondria, Muscle, Cell Respiration, Carbohydrate Metabolism, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients. https://app.cochat.ai/papers/10.2337/db08-0391
- The paper
- Phielix, E., Schrauwen-Hinderling, V. B., Mensink, M., Lenaers, E., Meex, R., Hoeks, J., Kooi, M. E., Moonen-Kornips, E., Sels, J.-P., Hesselink, M. K. C., & Schrauwen, P. (2008). Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients. Diabetes. https://doi.org/10.2337/db08-0391
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.